Skip to main content

FDA pulls preterm-birth drug Makena and its generics from market after 12 years

The drug, which was approved using an accelerated pathway in 2011, showed no clinical benefit in a later trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.